Product
Combination of Pembrolizumab and Platinum
1 clinical trial
1 indication
Indication
Esophageal cancerClinical trial
A Single Arm, Single Center, Phase II Clinical Study of Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2026-02-25